Could blood particles reveal secrets of rare lung disease LAM?

NCT ID NCT07304856

Recruiting now Knowledge-focused Sponsor: University of Milan Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at tiny particles called extracellular vesicles in the blood of women with a rare lung disease called LAM. Researchers want to see if these particles can act as biomarkers to show how the lungs are affected. The study will compare women with different forms of LAM and healthy controls. It does not test any treatment, but aims to improve understanding of the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify new biomarkers to help monitor lung disease in LAM patients, potentially leading to earlier detection or better tracking of disease progression.
What could go wrong: This is an early observational study, not a treatment trial. It may not find clear biomarkers, and any findings will need much more research before they could help patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACELLULAR VESICLES; GENERATION AND FUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphangioleiomyomatosis tuberous sclerosis 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXTRACELLULAR VESICLES; GENERATION AND FUNCTION LYMPHANGIOLEIOMYOMATOSIS (LAM)

Contacts and locations

Locations

Pulmonology Unit ASST Santi Paolo e Carlo, Ospedale San Paolo
RECRUITING

Milan, Milano, 20142, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.